Baidu
map

CELL:线粒体过度激活导致社会行为障碍

2020-05-17 MedSci原创 MedSci原创

社交障碍经常与线粒体功能障碍和神经递质改变有关。虽然线粒体功能对大脑的平衡至关重要,但线粒体功能的损伤是否会导致社会行为障碍仍是未知数。

社交障碍经常与线粒体功能障碍和神经递质改变有关。虽然线粒体功能对大脑的平衡至关重要,但线粒体功能的损伤是否会导致社会行为障碍仍是未知数。

最近,研究人员表明,在人类CYFIP1的同源基因具有突变的果蝇,一个与自闭症和精神分裂症有关的基因,表现出线粒体的过度激活和群体行为的改变。

此外,研究人员还确定了线粒体活动对GABA可用性的调节是其背后的生物学相关机制,并证明其对社会行为的贡献。具体来说,线粒体活动的增加会导致线粒体中γ-氨基丁酸(GABA)的封存,减少GABA能信号传导,导致社交障碍。

线粒体活性或GABA信号转导的药物和基因操纵可纠正所观察到的异常。研究人员还确定了Aralar是线粒体转运体,在线粒体活性增加时,会使GABA封存发生。

这项研究增加了我们对线粒体如何在生理病理条件下调节神经元平衡和社会行为的理解。

 

原始出处:

Kanellopoulos AK, Mariano V, Spinazzi M, et al. Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits. Cell. 2020;180(6):1178‐1197.e20. doi:10.1016/j.cell.2020.02.04

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1709769, encodeId=f7171e097692d, content=<a href='/topic/show?id=3c0e90045ac' target=_blank style='color:#2F92EE;'>#行为障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90045, encryptionId=3c0e90045ac, topicName=行为障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=895a31785550, createdName=12498cb5m23暂无昵称, createdTime=Thu Oct 22 22:44:51 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892644, encodeId=244989264463, content=精神分裂自闭怎么吃药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7855426457, createdName=ms2000001981254854, createdTime=Sat Oct 17 13:12:56 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962050, encodeId=1a3f196205059, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 22 01:44:51 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871754, encodeId=291f18e175461, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Fri Jun 19 21:44:51 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617015, encodeId=95a8161e0153a, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 19 03:44:51 CST 2020, time=2020-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1709769, encodeId=f7171e097692d, content=<a href='/topic/show?id=3c0e90045ac' target=_blank style='color:#2F92EE;'>#行为障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90045, encryptionId=3c0e90045ac, topicName=行为障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=895a31785550, createdName=12498cb5m23暂无昵称, createdTime=Thu Oct 22 22:44:51 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892644, encodeId=244989264463, content=精神分裂自闭怎么吃药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7855426457, createdName=ms2000001981254854, createdTime=Sat Oct 17 13:12:56 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962050, encodeId=1a3f196205059, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 22 01:44:51 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871754, encodeId=291f18e175461, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Fri Jun 19 21:44:51 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617015, encodeId=95a8161e0153a, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 19 03:44:51 CST 2020, time=2020-05-19, status=1, ipAttribution=)]
    2020-10-17 ms2000001981254854

    精神分裂自闭怎么吃药?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1709769, encodeId=f7171e097692d, content=<a href='/topic/show?id=3c0e90045ac' target=_blank style='color:#2F92EE;'>#行为障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90045, encryptionId=3c0e90045ac, topicName=行为障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=895a31785550, createdName=12498cb5m23暂无昵称, createdTime=Thu Oct 22 22:44:51 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892644, encodeId=244989264463, content=精神分裂自闭怎么吃药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7855426457, createdName=ms2000001981254854, createdTime=Sat Oct 17 13:12:56 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962050, encodeId=1a3f196205059, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 22 01:44:51 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871754, encodeId=291f18e175461, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Fri Jun 19 21:44:51 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617015, encodeId=95a8161e0153a, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 19 03:44:51 CST 2020, time=2020-05-19, status=1, ipAttribution=)]
    2020-12-22 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1709769, encodeId=f7171e097692d, content=<a href='/topic/show?id=3c0e90045ac' target=_blank style='color:#2F92EE;'>#行为障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90045, encryptionId=3c0e90045ac, topicName=行为障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=895a31785550, createdName=12498cb5m23暂无昵称, createdTime=Thu Oct 22 22:44:51 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892644, encodeId=244989264463, content=精神分裂自闭怎么吃药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7855426457, createdName=ms2000001981254854, createdTime=Sat Oct 17 13:12:56 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962050, encodeId=1a3f196205059, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 22 01:44:51 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871754, encodeId=291f18e175461, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Fri Jun 19 21:44:51 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617015, encodeId=95a8161e0153a, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 19 03:44:51 CST 2020, time=2020-05-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1709769, encodeId=f7171e097692d, content=<a href='/topic/show?id=3c0e90045ac' target=_blank style='color:#2F92EE;'>#行为障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90045, encryptionId=3c0e90045ac, topicName=行为障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=895a31785550, createdName=12498cb5m23暂无昵称, createdTime=Thu Oct 22 22:44:51 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892644, encodeId=244989264463, content=精神分裂自闭怎么吃药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7855426457, createdName=ms2000001981254854, createdTime=Sat Oct 17 13:12:56 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962050, encodeId=1a3f196205059, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Dec 22 01:44:51 CST 2020, time=2020-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871754, encodeId=291f18e175461, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Fri Jun 19 21:44:51 CST 2020, time=2020-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617015, encodeId=95a8161e0153a, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue May 19 03:44:51 CST 2020, time=2020-05-19, status=1, ipAttribution=)]

相关资讯

SCI ADV:靶向神经元线粒体稳态的新方法

线粒体动力学和功能受损是许多神经系统和精神疾病的标志,但至今为止,还没有报道利用神经元直接筛选线粒体治疗药物的先例。

PNAS:线粒体膜温和去极化可以抗衰老?

在寿命较短的小鼠衰老过程中,ROS介导的蛋白损伤在寿命较长的裸鼹鼠和蝙蝠衰老过程中稳定在低水平。这提示我们,线粒体轻度去极化是线粒体抗衰老系统的重要组成部分。

Sci Rep:氧化磷酸化基因高表达可预测肺部鳞状细胞癌的生存率改善

这些数据为旨在表征肿瘤线粒体活性与肿瘤免疫微环境之间相互作用的研究提供了有力支持。

Nat Commun:OXPHOS在高等级前列腺癌中的重构参与了mtDNA变异并增加琥珀酸氧化

能量代谢的重组和线粒体的适应被认为影响了前列腺癌的发展和恶化。最近,有研究人员报道了良性/恶性人类前列腺组织样本中,线粒体呼吸、DNA变异和基因表达的情况。

CELL:CRISPR技术寻找氧稳态相关的线粒体和脂代谢途径

人体细胞能够感知和适应氧水平的变化。从历史上看,这一领域的许多研究都集中在缺氧诱导因子(HIF)信号转导和活性氧物种(ROS)上。

CELL METAB:“神药”二甲双胍减轻衰老相关炎症反应

衰老是年龄相关疾病伴随的炎症的一个不可改变的危险因素;因此,抗炎药有希望可以延长健康寿命。

Baidu
map
Baidu
map
Baidu
map